---
figid: PMC7317062__vdz047f0001
figlink: pmc/articles/PMC7317062/figure/F1/
number: F1
caption: Neurofibromin is a negative RAS regulator. Growth factor binding to cognate
  receptor tyrosine kinases (EGFR, RTK) or chemokine binding to G-protein coupled
  receptors (GPCR) lead to activation of RAS and subsequent phosphorylation of downstream
  RAS effectors, including AKT (mTOR) and RAF (MEK/ERK). Neurofibromin functions in
  part as a RAS-GTPase activating-related protein that stimulates inherent GTPase
  activity of RAS, increasing the conversion of active GTP-RAS to inactive GDP-RAS.
  Loss of neurofibromin leads to increased RAS/RAF effector activity, and greater
  cell growth. Signals from the microenvironment, HIPPO pathway, Janus kinases, epigenetic
  regulators, and protein stability pathways also contribute to malignant cell growth.
  Drugs that have been tested in clinical trials for MPNST are depicted in red alongside
  their respective targets. Potential drug targets to include in novel combinations
  for MPNST are depicted in blue alongside the respective targets.
pmcid: PMC7317062
papertitle: 'Diagnosis and management of malignant peripheral nerve sheath tumors:
  Current practice and future perspectives.'
reftext: Bethany C Prudner, et al. Neurooncol Adv. 2020 Jul;2(Suppl 1):i40-i49.
pmc_ranked_result_index: '80670'
pathway_score: 0.9659598
filename: vdz047f0001.jpg
figtitle: Neurofibromin is a negative RAS regulator
year: '2020'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7317062__vdz047f0001.html
  '@type': Dataset
  description: Neurofibromin is a negative RAS regulator. Growth factor binding to
    cognate receptor tyrosine kinases (EGFR, RTK) or chemokine binding to G-protein
    coupled receptors (GPCR) lead to activation of RAS and subsequent phosphorylation
    of downstream RAS effectors, including AKT (mTOR) and RAF (MEK/ERK). Neurofibromin
    functions in part as a RAS-GTPase activating-related protein that stimulates inherent
    GTPase activity of RAS, increasing the conversion of active GTP-RAS to inactive
    GDP-RAS. Loss of neurofibromin leads to increased RAS/RAF effector activity, and
    greater cell growth. Signals from the microenvironment, HIPPO pathway, Janus kinases,
    epigenetic regulators, and protein stability pathways also contribute to malignant
    cell growth. Drugs that have been tested in clinical trials for MPNST are depicted
    in red alongside their respective targets. Potential drug targets to include in
    novel combinations for MPNST are depicted in blue alongside the respective targets.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CXCL1
  - CXCL2
  - CXCL10
  - CXCL9
  - CXCL6
  - CXCL11
  - CXCL5
  - CXCL14
  - CXCL3
  - CXCL8
  - PF4
  - PPBP
  - CXCL12
  - CXCL13
  - EGFR
  - JAK1
  - HRAS
  - KRAS
  - NRAS
  - NF2
  - LATS1
  - LATS2
  - NF1
  - STAT1
  - STAT5A
  - STAT6
  - STAT2
  - STAT3
  - STAT4
  - STAT5B
  - TAZ
  - YY1AP1
  - HSP90B1
  - TRAP1
  - HSP90AB1
  - ARAF
  - BRAF
  - RAF1
  - AKT2
  - AKT3
  - AKT1
  - MAP2K1
  - MAP2K2
  - MAPK3
  - MAPK1
  - Sorafenib
  - Imatinib
  - dasatinib
  - pexidartinib
  - Erlotinib
  - GDP
  - Sirolimus
genes:
- word: Chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL1
  entrez: '2919'
- word: Chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL2
  entrez: '2920'
- word: Chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL10
  entrez: '3627'
- word: Chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL9
  entrez: '4283'
- word: Chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL6
  entrez: '6372'
- word: Chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL11
  entrez: '6373'
- word: Chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL5
  entrez: '6374'
- word: Chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL14
  entrez: '9547'
- word: Chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL3
  entrez: '2921'
- word: Chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: Chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: PF4
  entrez: '5196'
- word: Chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: PPBP
  entrez: '5473'
- word: Chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL12
  entrez: '6387'
- word: Chemokine
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL13
  entrez: '10563'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: JAK1
  symbol: JAK1
  source: hgnc_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: NF2
  symbol: NF2
  source: hgnc_symbol
  hgnc_symbol: NF2
  entrez: '4771'
- word: LATS1/2
  symbol: LATS1
  source: hgnc_symbol
  hgnc_symbol: LATS1
  entrez: '9113'
- word: LATS1/2
  symbol: LATS2
  source: hgnc_symbol
  hgnc_symbol: LATS2
  entrez: '26524'
- word: NF1
  symbol: NF1
  source: hgnc_symbol
  hgnc_symbol: NF1
  entrez: '4763'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: (YAP/TAZ
  symbol: TAZ
  source: hgnc_symbol
  hgnc_symbol: TAZ
  entrez: '6901'
- word: (YAP/TAZ
  symbol: YAP
  source: hgnc_alias_symbol
  hgnc_symbol: YY1AP1
  entrez: '55249'
- word: (HSP90)
  symbol: HSP90
  source: bioentities_symbol
  hgnc_symbol: HSP90B1
  entrez: '7184'
- word: (HSP90)
  symbol: HSP90
  source: bioentities_symbol
  hgnc_symbol: TRAP1
  entrez: '10131'
- word: (HSP90)
  symbol: HSP90
  source: bioentities_symbol
  hgnc_symbol: HSP90AB1
  entrez: '3326'
- word: YAP/TAZ
  symbol: TAZ
  source: hgnc_symbol
  hgnc_symbol: TAZ
  entrez: '6901'
- word: YAP/TAZ
  symbol: YAP
  source: hgnc_alias_symbol
  hgnc_symbol: YY1AP1
  entrez: '55249'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
chemicals:
- word: Sorafenib
  source: MESH
  identifier: C471405
- word: Imatinib
  source: MESH
  identifier: C097613
- word: dasatinib
  source: MESH
  identifier: C488369
- word: pexidartinib
  source: ''
  identifier: ''
- word: Erlotinib
  source: MESH
  identifier: C400278
- word: GDP
  source: MESH
  identifier: D006153
- word: Sirolimus
  source: MESH
  identifier: D020123
diseases: []
figid_alias: PMC7317062__F1
redirect_from: /figures/PMC7317062__F1
figtype: Figure
---
